Not Tagged
Not Tagged
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'congrat']
congrats to study team but this raises some major eyebrows. 1% of pts had a grade 3 side effect with combo-ldr? that is unprecedented. ascende showed &gt;30% any grade3. 10% in nccn high risk had bcr with 6m adt and combo brachy?
#gu23 
Vincent Smith Professor and Chair of Radiation Oncology University Hospitals Seidman Cancer Center Case Western Reserve University SOM.  *TWEETS are my own*